Increased expression of Srebp2 and Srebp1a in livers of newborn heterozygous mice is postulated also to contribute to the development of NAFLD in adult Tmed299J/+ mice. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.